LUMOS DIAGNOSTICS HOLDINGS LIMITED - Announcements

3.80%

9.6¢

Market Cap $69.61M

Healthcare Medical Instruments & Supplies

Lumos Diagnostics Holdings Limited is an Australia-based company specializes in... Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. It manages the full development program for POC assays.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	358.63KB	Share
LDX	Operational Review & Management Reorganisation	PRICE SENSITIVE	11/04/22	200.16KB	Share
LDX	FebriDx Update - Brazil Market Authorisation & New Study	PRICE SENSITIVE	28/02/22	211.91KB	Share
LDX	FY2022 Half Year Update	PRICE SENSITIVE	28/02/22	4.04MB	Share
LDX	Lumos Diagnostics FY22 First Half Year Results	PRICE SENSITIVE	28/02/22	228.74KB	Share
LDX	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/22	1.65MB	Share
LDX	Change To Lumos Board	PRICE SENSITIVE	11/02/22	152.49KB	Share
LDX	Victorian Government Intent for Lumos Manufacturing Hub	PRICE SENSITIVE	02/02/22	231.9KB	Share
LDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	348.29KB	Share
LDX	Over 100 Pharmacies in Liverpool UK Launch FebriDx Service	PRICE SENSITIVE	12/01/22	155.16KB	Share
LDX	Lumos Provides ViraDx and FebriDx Regulatory Update	PRICE SENSITIVE	22/12/21	213.26KB	Share
LDX	Lumos Receives Initial Orders for CoviDx In Canada	PRICE SENSITIVE	20/12/21	183.62KB	Share
LDX	LDX received authorization to sell CoviDx in Canada	PRICE SENSITIVE	03/11/21	186.08KB	Share
LDX	Monthly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/10/21	332.43KB	Share
LDX	Update on Economic Evaluation of FebriDx	PRICE SENSITIVE	08/10/21	178.45KB	Share
LDX	Trading Halt	PRICE SENSITIVE	06/10/21	128.83KB	Share
LDX	Pause in Trading	PRICE SENSITIVE	06/10/21	116.31KB	Share
LDX	Economic Evaluation of FebriDx	PRICE SENSITIVE	06/10/21	191.47KB	Share
LDX	U.S FDA Deprioritises EUA Application for CoviDx	PRICE SENSITIVE	22/09/21	156.2KB	Share
LDX	FY21 Full Year Results Investor Presentation	PRICE SENSITIVE	30/08/21	10.57MB	Share
LDX	FY21 Full Year Results Media Release	PRICE SENSITIVE	30/08/21	189.8KB	Share
LDX	FY21 Appendix 4E	PRICE SENSITIVE	30/08/21	44.33KB	Share

LDX Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	358.63KB	Share
LDX Operational Review & Management Reorganisation
11/04/22	PRICE SENSITIVE	200.16KB	Share
LDX FebriDx Update - Brazil Market Authorisation & New Study
28/02/22	PRICE SENSITIVE	211.91KB	Share
LDX FY2022 Half Year Update
28/02/22	PRICE SENSITIVE	4.04MB	Share
LDX Lumos Diagnostics FY22 First Half Year Results
28/02/22	PRICE SENSITIVE	228.74KB	Share
LDX Appendix 4D and Half Year Report
28/02/22	PRICE SENSITIVE	1.65MB	Share
LDX Change To Lumos Board
11/02/22	PRICE SENSITIVE	152.49KB	Share
LDX Victorian Government Intent for Lumos Manufacturing Hub
02/02/22	PRICE SENSITIVE	231.9KB	Share
LDX Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	348.29KB	Share
LDX Over 100 Pharmacies in Liverpool UK Launch FebriDx Service
12/01/22	PRICE SENSITIVE	155.16KB	Share
LDX Lumos Provides ViraDx and FebriDx Regulatory Update
22/12/21	PRICE SENSITIVE	213.26KB	Share
LDX Lumos Receives Initial Orders for CoviDx In Canada
20/12/21	PRICE SENSITIVE	183.62KB	Share
LDX LDX received authorization to sell CoviDx in Canada
03/11/21	PRICE SENSITIVE	186.08KB	Share
LDX Monthly Activities/Appendix 4C Cash Flow Report
27/10/21	PRICE SENSITIVE	332.43KB	Share
LDX Update on Economic Evaluation of FebriDx
08/10/21	PRICE SENSITIVE	178.45KB	Share
LDX Trading Halt
06/10/21	PRICE SENSITIVE	128.83KB	Share
LDX Pause in Trading
06/10/21	PRICE SENSITIVE	116.31KB	Share
LDX Economic Evaluation of FebriDx
06/10/21	PRICE SENSITIVE	191.47KB	Share
LDX U.S FDA Deprioritises EUA Application for CoviDx
22/09/21	PRICE SENSITIVE	156.2KB	Share
LDX FY21 Full Year Results Investor Presentation
30/08/21	PRICE SENSITIVE	10.57MB	Share
LDX FY21 Full Year Results Media Release
30/08/21	PRICE SENSITIVE	189.8KB	Share
LDX FY21 Appendix 4E
30/08/21	PRICE SENSITIVE	44.33KB	Share

REFRESH

First

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.6¢		Change 0.004(3.80%)		Mkt cap ! $69.61M

Open	High	Low	Value	Volume
9.3¢	9.6¢	9.3¢	$170.5K	1.810M

Buyers (Bids)

No.	Vol.	Price($)
2	160268	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.6¢	399953	6

View Market Depth

No.	Vol.	Price($)
1	9965	0.094
8	454848	0.093
7	815997	0.092
5	912561	0.091
5	227000	0.090

Price($)	Vol.	No.
0.096	399953	6
0.097	534160	7
0.098	339092	6
0.099	546092	4
0.100	428138	11

Last trade - 13.33pm 11/08/2025 (20 minute delay)


Last 9.8¢		Change 0.004 ( 5.98 %)
Open	High	Low	Volume
9.4¢	9.8¢	9.2¢	703774
Last updated 13.50pm 11/08/2025 ?

LDX (ASX) Chart

LUMOS DIAGNOSTICS HOLDINGS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available